vs
Side-by-side financial comparison of Spero Therapeutics, Inc. (SPRO) and Village Farms International, Inc. (VFF). Click either name above to swap in a different company.
Spero Therapeutics, Inc. is the larger business by last-quarter revenue ($12.6M vs $12.2M, roughly 1.0× Village Farms International, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 19.9%, a 230.8% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 31.5%).
Grafton Village Cheese Company is a cheesemaker in the town of Grafton in the U.S. state of Vermont. The company produces hand-crafted aged cheddar cheese.
SPRO vs VFF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.6M | $12.2M |
| Net Profit | $31.5M | $2.4M |
| Gross Margin | — | — |
| Operating Margin | — | — |
| Net Margin | 250.7% | 19.9% |
| Revenue YoY | 24080.8% | 31.5% |
| Net Profit YoY | 250.9% | 128.2% |
| EPS (diluted) | $0.56 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.6M | $12.2M | ||
| Q3 25 | $0 | $66.7M | ||
| Q2 25 | $0 | $59.9M | ||
| Q1 25 | $12.0K | $77.1M | ||
| Q4 24 | $52.0K | — | ||
| Q3 24 | $65.0K | $54.9M | ||
| Q2 24 | $114.0K | $53.6M | ||
| Q1 24 | $140.0K | $78.1M |
| Q4 25 | $31.5M | $2.4M | ||
| Q3 25 | $-7.4M | $10.2M | ||
| Q2 25 | $-1.7M | $26.5M | ||
| Q1 25 | $-13.9M | $-6.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-17.1M | $-820.0K | ||
| Q2 24 | $-17.9M | $-23.5M | ||
| Q1 24 | $-12.7M | $-2.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | 47.9% | ||
| Q2 25 | — | 37.3% | ||
| Q1 25 | — | 14.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.8% | ||
| Q2 24 | — | 25.4% | ||
| Q1 24 | — | 19.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 23.3% | ||
| Q2 25 | — | 20.8% | ||
| Q1 25 | -122758.3% | -8.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | -28604.6% | 3.8% | ||
| Q2 24 | -16720.2% | -43.5% | ||
| Q1 24 | -9987.1% | -3.0% |
| Q4 25 | 250.7% | 19.9% | ||
| Q3 25 | — | 15.3% | ||
| Q2 25 | — | 44.2% | ||
| Q1 25 | -115550.0% | -8.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | -26380.0% | -1.5% | ||
| Q2 24 | -15668.4% | -43.9% | ||
| Q1 24 | -9049.3% | -3.7% |
| Q4 25 | $0.56 | $0.01 | ||
| Q3 25 | $-0.13 | $0.08 | ||
| Q2 25 | $-0.03 | $0.24 | ||
| Q1 25 | $-0.25 | $-0.06 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.32 | $-0.01 | ||
| Q2 24 | $-0.33 | $-0.21 | ||
| Q1 24 | $-0.24 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.3M | $81.2M |
| Total DebtLower is stronger | — | $33.7M |
| Stockholders' EquityBook value | $59.0M | $299.9M |
| Total Assets | $68.9M | $423.1M |
| Debt / EquityLower = less leverage | — | 0.11× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.3M | $81.2M | ||
| Q3 25 | $48.6M | $82.6M | ||
| Q2 25 | $31.2M | $60.0M | ||
| Q1 25 | $48.9M | $15.1M | ||
| Q4 24 | $52.9M | — | ||
| Q3 24 | $76.3M | $28.7M | ||
| Q2 24 | $63.5M | $29.7M | ||
| Q1 24 | $82.3M | $26.7M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | — | $34.6M | ||
| Q2 25 | — | $39.1M | ||
| Q1 25 | — | $39.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $43.3M | ||
| Q2 24 | — | $44.4M | ||
| Q1 24 | — | $46.1M |
| Q4 25 | $59.0M | $299.9M | ||
| Q3 25 | $26.5M | $295.4M | ||
| Q2 25 | $32.8M | $284.3M | ||
| Q1 25 | $33.8M | $248.3M | ||
| Q4 24 | $46.1M | — | ||
| Q3 24 | $65.5M | $274.4M | ||
| Q2 24 | $80.5M | $275.2M | ||
| Q1 24 | $96.2M | $296.2M |
| Q4 25 | $68.9M | $423.1M | ||
| Q3 25 | $54.2M | $418.4M | ||
| Q2 25 | $62.1M | $403.7M | ||
| Q1 25 | $77.7M | $377.1M | ||
| Q4 24 | $110.5M | — | ||
| Q3 24 | $135.2M | $417.8M | ||
| Q2 24 | $149.9M | $425.4M | ||
| Q1 24 | $167.7M | $458.4M |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.14× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 0.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.4M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 90.8% |
| Cash ConversionOCF / Net Profit | -0.26× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.4M | — | ||
| Q3 25 | $17.4M | $24.4M | ||
| Q2 25 | $-17.7M | — | ||
| Q1 25 | $-4.0M | $-6.4M | ||
| Q4 24 | $-23.4M | — | ||
| Q3 24 | $12.8M | $4.3M | ||
| Q2 24 | $-18.7M | $5.7M | ||
| Q1 24 | $5.9M | $-50.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | $22.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-8.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | — | $4.8M | ||
| Q1 24 | — | $-1.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | 33.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -11.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 9.0% | ||
| Q1 24 | — | -2.5% |
| Q4 25 | — | 90.8% | ||
| Q3 25 | — | 2.7% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.1% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 2.4% |
| Q4 25 | -0.26× | — | ||
| Q3 25 | — | 2.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SPRO
Segment breakdown not available.
VFF
| International Sales | $8.7M | 71% |
| Cannabis United States Segment | $3.4M | 27% |
